Eli Lilly Nears First Trillion Pharma Title, But Investors Caution Amid Sky-High Valuation
2024-10-02 13
Eli Lilly's valuation stands at $842 billion, 54x projected earnings. Orforglipron could be the first small-molecule weight-loss pill when it launches in 2026, giving Eli Lilly two-year lead before rivals catch
